{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:30:04Z","timestamp":1786995004857,"version":"build-2736575974"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010044","name":"University of Central Lancashire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010044","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.neuropharm.2025.110482","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T22:42:32Z","timestamp":1745534552000},"page":"110482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Personality disorders: A preface"],"prefix":"10.1016","volume":"274","author":[{"given":"Lorenzo","family":"More","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110482_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110322","article-title":"Neurobiology, molecular pathways, and environmental influences in antisocial traits and personality disorders","volume":"269","author":"Adamczyk","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110482_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110413","article-title":"Exploring serotonergic psychedelics as a treatment for personality disorders","volume":"272","author":"Carrithers","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110482_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110179","article-title":"The role of gene-environment interactions in social dysfunction: focus on preclinical evidence from mouse studies","volume":"261","author":"Castellano","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110482_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110150","article-title":"The neurobiology of antisocial personality disorder","volume":"261","author":"Choy","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110482_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110436","article-title":"Fatty acid amide hydrolase in comorbid borderline personality disorder and major depressive disorder: imaging with [(11)C]CURB PET","author":"De Pol","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110482_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110117","article-title":"Neurolipidomics in schizophrenia: a not so well-oiled machine","volume":"260","author":"Del Campo","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110482_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110209","article-title":"Adenosine regulates depressive behavior in mice with chronic social defeat stress through gut microbiota","volume":"262","author":"Huang","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110482_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110321","article-title":"Antisocial personality disorder:Failure to balance excitation\/inhibition?","volume":"268","author":"Lesch","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110482_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110021","article-title":"Associations of the immune system in aggression traits and the role of microglia as mediators","volume":"256","author":"Takahashi","year":"2024","journal-title":"Neuropharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825001881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825001881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T16:12:19Z","timestamp":1746720739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825001881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":9,"alternative-id":["S0028390825001881"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110482","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Personality disorders: A preface","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110482"}}